BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8634919)

  • 1. Prevention of nitrate tolerance with concomitant administration of hydralazine.
    Elkayam U
    Can J Cardiol; 1996 May; 12 Suppl C():17C-21C. PubMed ID: 8634919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance.
    Csont T; Ferdinandy P
    Pharmacol Ther; 2005 Jan; 105(1):57-68. PubMed ID: 15626455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.
    Daiber A; Mülsch A; Hink U; Mollnau H; Warnholtz A; Oelze M; Münzel T
    Am J Cardiol; 2005 Oct; 96(7B):25i-36i. PubMed ID: 16226933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrate tolerance and dependence. A critical assessment.
    Abrams J
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2499-504. PubMed ID: 6775305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
    Elkayam U; Bitar F
    Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
    Packer M; Lee WH; Kessler PD; Gottlieb SS; Medina N; Yushak M
    N Engl J Med; 1987 Sep; 317(13):799-804. PubMed ID: 3114637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.
    Münzel T; Kurz S; Rajagopalan S; Thoenes M; Berrington WR; Thompson JA; Freeman BA; Harrison DG
    J Clin Invest; 1996 Sep; 98(6):1465-70. PubMed ID: 8823313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
    Klemenska E; Beresewicz A
    Cardiol J; 2009; 16(1):11-9. PubMed ID: 19130411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol compounds and organic nitrates.
    Boesgaard S
    Dan Med Bull; 1995 Nov; 42(5):473-84. PubMed ID: 8747803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.
    Rudolph W; Dirschinger J; Kraus F; Reiniger G; Hall D
    Z Kardiol; 1990; 79 Suppl 3():57-65. PubMed ID: 2099042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
    Thadani U
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):735-42. PubMed ID: 9110117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the use of transdermal nitroglycerin systems.
    Zeller FP; Klamerus KJ
    Clin Pharm; 1987 Aug; 6(8):605-16. PubMed ID: 3121239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrate therapy for heart failure: benefits and strategies to overcome tolerance.
    Gupta D; Georgiopoulou VV; Kalogeropoulos AP; Marti CN; Yancy CW; Gheorghiade M; Fonarow GC; Konstam MA; Butler J
    JACC Heart Fail; 2013 Jun; 1(3):183-91. PubMed ID: 24621868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic nitrate tolerance and endothelial dysfunction: role of folate therapy.
    Leopold JA; Loscalzo J
    Minerva Cardioangiol; 2003 Aug; 51(4):349-59. PubMed ID: 12900717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organic nitrates: still interesting after all these years].
    Lisi M; Parker JD; Gori T
    Recenti Prog Med; 2009 Mar; 100(3):140-3. PubMed ID: 19475842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.